MedTrace Logo

Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19

NCT04949074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-03-09

No results posted yet for this study

Summary

Constitution of a collection of SARS-CoV-2 RNA extracts from nasopharyngeal and saliva / sputum samples, from the same patients (paired samples), taken during the same consultation in an indication of detection of SARS-CoV-2 in with a view to developing tests / diagnostic tools for SARS-CoV-2.

Conditions

  • Respiratory Tract Infections

Interventions

OTHER

saliva sampling

when the patient goes to the laboratory for a covid 19 diagnostic from a routine nasopharingeal sample, an additionnal sample of saliva is asked

Sponsors & Collaborators

  • ID Solutions

    lead INDUSTRY

Principal Investigators

  • Jeremy M Bayette, Dr · Labosud

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-12-15
Completion
2022-12-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949074 on ClinicalTrials.gov